Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon

The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IH...

Full description

Saved in:
Bibliographic Details
Published inJournal of the neurological sciences Vol. 285; no. 1; pp. 149 - 153
Main Authors Njamnshi, A.K., Zoung-Kanyi Bissek, A.C., Ongolo-Zogo, P., Tabah, E.N., Lekoubou, A.Z., Yepnjio, F.N., Fonsah, J.Y., Kuate, C.T., Angwafor, S.A., Dema, F., Njamnshi, D.M., Kouanfack, C., Djientcheu, V. de P., Muna, W.F.T., Kanmogne, G.D.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 15.10.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393–397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score ≤ 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P ≤ 0.05. A binary logistic regression was used to determine independent risk factors. The following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P = 0.001), low CD4 count especially CD4 ≤ 200 cells/µL (OR = 4.88, P = 0.045) and low hemoglobin concentration (OR = 1.16, P = 0.048). This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.
AbstractList AbstractBackgroundThe prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393–397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. Patients and methodsA cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score ≤ 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P≤ 0.05. A binary logistic regression was used to determine independent risk factors. ResultsThe following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P= 0.001), low CD4 count especially CD4 ≤ 200 cells/µL (OR = 4.88, P= 0.045) and low hemoglobin concentration (OR = 1.16, P= 0.048). ConclusionThis first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.
The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD.BACKGROUNDThe prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD.A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score < or = 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P < or = 0.05. A binary logistic regression was used to determine independent risk factors.PATIENTS AND METHODSA cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score < or = 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P < or = 0.05. A binary logistic regression was used to determine independent risk factors.The following factors were independent predictors of HAND: advanced clinical stage (OR=7.43, P=0.001), low CD4 count especially CD4 < or = 200 cells/microL (OR=4.88, P=0.045) and low hemoglobin concentration (OR=1.16, P=0.048).RESULTSThe following factors were independent predictors of HAND: advanced clinical stage (OR=7.43, P=0.001), low CD4 count especially CD4 < or = 200 cells/microL (OR=4.88, P=0.045) and low hemoglobin concentration (OR=1.16, P=0.048).This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.CONCLUSIONThis first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.
The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaounde [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaounde-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008; 49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. Patients and methods - A cross-sectional study was conducted in Yaounde, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score <= 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P <= 0.05. A binary logistic regression was used to determine independent risk factors. Results - The following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P = 0.001), low CD4 count especially CD4 <= 200 cells/kL (OR = 4.88, P = 0.045) and low hemoglobin concentration (OR = 1.16, P = 0.048). Conclusion - This first study of the risk factors for HAND in Yaounde-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.
The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score < or = 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P < or = 0.05. A binary logistic regression was used to determine independent risk factors. The following factors were independent predictors of HAND: advanced clinical stage (OR=7.43, P=0.001), low CD4 count especially CD4 < or = 200 cells/microL (OR=4.88, P=0.045) and low hemoglobin concentration (OR=1.16, P=0.048). This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.
The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393–397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score ≤ 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P ≤ 0.05. A binary logistic regression was used to determine independent risk factors. The following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P = 0.001), low CD4 count especially CD4 ≤ 200 cells/µL (OR = 4.88, P = 0.045) and low hemoglobin concentration (OR = 1.16, P = 0.048). This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.
Author Dema, F.
Muna, W.F.T.
Angwafor, S.A.
Kouanfack, C.
Kanmogne, G.D.
Zoung-Kanyi Bissek, A.C.
Lekoubou, A.Z.
Djientcheu, V. de P.
Kuate, C.T.
Tabah, E.N.
Yepnjio, F.N.
Njamnshi, A.K.
Njamnshi, D.M.
Ongolo-Zogo, P.
Fonsah, J.Y.
Author_xml – sequence: 1
  givenname: A.K.
  surname: Njamnshi
  fullname: Njamnshi, A.K.
  email: aknjamnshi@yahoo.co.uk
  organization: Neurology Department, Central Hospital & Faculty of Med. & Biomed. Sciences (FMBS), University of Yaounde 1 (UY1), BP 25625, Yaounde, Cameroon
– sequence: 2
  givenname: A.C.
  surname: Zoung-Kanyi Bissek
  fullname: Zoung-Kanyi Bissek, A.C.
  organization: Dept. of Int. Med. & Specialties, FMBS, UY1, Yaounde, Cameroon
– sequence: 3
  givenname: P.
  surname: Ongolo-Zogo
  fullname: Ongolo-Zogo, P.
  organization: Medical Imaging Dept, Central Hospital, Yaounde & FMBS, UY1, Cameroon
– sequence: 4
  givenname: E.N.
  surname: Tabah
  fullname: Tabah, E.N.
  organization: Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 5
  givenname: A.Z.
  surname: Lekoubou
  fullname: Lekoubou, A.Z.
  organization: Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 6
  givenname: F.N.
  surname: Yepnjio
  fullname: Yepnjio, F.N.
  organization: Fann Teaching Hospital, Dakar & Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 7
  givenname: J.Y.
  surname: Fonsah
  fullname: Fonsah, J.Y.
  organization: Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 8
  givenname: C.T.
  surname: Kuate
  fullname: Kuate, C.T.
  organization: Neurology Department, Central Hospital & Faculty of Med. & Biomed. Sciences (FMBS), University of Yaounde 1 (UY1), BP 25625, Yaounde, Cameroon
– sequence: 9
  givenname: S.A.
  surname: Angwafor
  fullname: Angwafor, S.A.
  organization: Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 10
  givenname: F.
  surname: Dema
  fullname: Dema, F.
  organization: Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 11
  givenname: D.M.
  surname: Njamnshi
  fullname: Njamnshi, D.M.
  organization: HIV Day Care Unit, Central Hospital, Yaounde, Cameroon
– sequence: 12
  givenname: C.
  surname: Kouanfack
  fullname: Kouanfack, C.
  organization: HIV Day Care Unit, Central Hospital, Yaounde, Cameroon
– sequence: 13
  givenname: V. de P.
  surname: Djientcheu
  fullname: Djientcheu, V. de P.
  organization: Neurology Dept, Central Hospital, Yaounde, Cameroon
– sequence: 14
  givenname: W.F.T.
  surname: Muna
  fullname: Muna, W.F.T.
  organization: Dept. of Int. Med. & Specialties, FMBS, UY1, Yaounde, Cameroon
– sequence: 15
  givenname: G.D.
  surname: Kanmogne
  fullname: Kanmogne, G.D.
  organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22347994$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19631349$$D View this record in MEDLINE/PubMed
BookMark eNqFks1uEzEUhS1URNPAA7BB3vC3mGCPPT8uUqUo_KRSBRItCFaWx77TOJ3YxZ6J1EfiOXgxZpoQQSXCygufc3zu9XeEDpx3gNBjSiaU0PzVcrJ0cZISIiYknxDO7qERLYsyycqSHaARIWmaZJR8PURHMS4JIXlZigfokIqcUcbFCLWfbLzCtdKtDxHXPuD56ZdExei1VS0Y7KALXvtLZ1u7Bmxs9MFAr30xn3548xJbh2NXJedqoYJyeFoHq9UxvlgA1ioC9jX-pnznzM8fyUytIHjvHqL7tWoiPNqeY_T53duL2Tw5-_j-dDY9S3TORJuUXNSaqJpDTaracMU1FbQEXfECBAVIK8OoKQqVVkWWFpBDYSpq8ozVhKmCjdHJJve6q1ZgNLg2qEZeB7tS4UZ6ZeXfN84u5KVfSy5ILjjrA55vA4L_3kFs5cpGDU2jHPguyoJxwmmWl73y2V5lSspU5DzrhU_-7LQr8_tLesHTrUBFrZq636q2cadLU8YL0Zcbo2Kj08HHGKCW2raqtX4YxTaSEjlAIpeyh0QOkEiSS3I7Fb3j3JXY43m98UD_X2sLQUZtwWkwNoBupfF2r_vkjls31vWgNFdwA3Hpu-B6ECSVMZVEng_gDtwSMSB7u17x74D_PP4LMpX-jA
CODEN JNSCAG
CitedBy_id crossref_primary_10_1038_s41598_018_20271_x
crossref_primary_10_1016_j_ejphar_2015_03_018
crossref_primary_10_1074_jbc_M111_262543
crossref_primary_10_1111_tmi_12449
crossref_primary_10_1155_2019_5173289
crossref_primary_10_1097_QAI_0000000000002242
crossref_primary_10_1097_QAI_0000000000002385
crossref_primary_10_1186_s40249_019_0544_6
crossref_primary_10_1016_j_ajp_2017_05_003
crossref_primary_10_1007_s11065_021_09527_y
crossref_primary_10_1007_s13365_012_0097_y
crossref_primary_10_1007_s10461_011_9988_9
crossref_primary_10_1016_j_drugalcdep_2013_12_021
crossref_primary_10_1186_1471_2377_10_60
crossref_primary_10_1002_alz_12432
crossref_primary_10_1111_hiv_12979
crossref_primary_10_3389_fnana_2017_00096
crossref_primary_10_1186_1471_2458_14_653
crossref_primary_10_17159_sajs_2021_8575
crossref_primary_10_1016_j_ijid_2013_06_011
crossref_primary_10_1038_s41598_020_70981_4
crossref_primary_10_1093_ije_dyt198
crossref_primary_10_1017_S1355617720000120
crossref_primary_10_1111_hiv_12137
crossref_primary_10_1007_s11604_021_01150_4
crossref_primary_10_1258_ijsa_2010_009554
crossref_primary_10_1017_S1041610219000413
crossref_primary_10_1136_bmjopen_2011_000662
crossref_primary_10_1155_2015_486960
crossref_primary_10_1080_03630242_2013_767301
crossref_primary_10_1111_j_1468_1293_2012_01043_x
crossref_primary_10_1007_s11481_013_9505_1
crossref_primary_10_1155_2019_8306823
crossref_primary_10_1097_NMD_0000000000000962
crossref_primary_10_4269_ajtmh_22_0234
crossref_primary_10_1186_1471_2377_13_86
crossref_primary_10_2217_fvl_11_71
crossref_primary_10_7759_cureus_18776
crossref_primary_10_1186_s12889_023_15935_x
crossref_primary_10_3390_pathogens13070568
crossref_primary_10_1097_QAI_0000000000000898
Cites_doi 10.1097/00002030-199305000-00012
10.1097/00002030-199808000-00002
10.1212/WNL.53.4.782
10.1080/13550280701829793
10.1097/QAI.0b013e318183a9df
10.1371/journal.pmed.1000066
10.1080/13550280590952790
10.1097/00002030-199910010-00011
10.1176/jnp.15.2.208
10.3109/13550280009006385
10.1097/00042560-200109010-00004
10.1001/archpedi.159.7.651
10.1212/01.wnl.0000225183.74521.72
10.1212/WNL.52.3.607
10.1097/00042560-199601010-00005
10.1080/13550280290049615
10.1212/01.wnl.0000252811.48891.6d
10.1089/088922204323087723
10.1186/1758-2652-12-5
10.1212/WNL.43.11.2245
10.1212/01.wnl.0000339042.96109.86
10.1097/00126334-200405010-00003
10.1056/NEJMp0902820
10.1212/01.WNL.0000287431.88658.8b
10.1592/phco.23.14.1475.31949
10.1176/jnp.17.2.180
10.1212/01.WNL.0000134665.58343.8D
ContentType Journal Article
Copyright 2009 Elsevier B.V.
Elsevier B.V.
2015 INIST-CNRS
Copyright_xml – notice: 2009 Elsevier B.V.
– notice: Elsevier B.V.
– notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
H94
7X8
5PM
DOI 10.1016/j.jns.2009.06.043
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
AIDS and Cancer Research Abstracts
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-5883
EndPage 153
ExternalDocumentID PMC4906943
19631349
22347994
10_1016_j_jns_2009_06_043
S0022510X09006868
1_s2_0_S0022510X09006868
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Africa
Africa South of the Sahara
Cameroon
GeographicLocations_xml – name: Cameroon
– name: Africa South of the Sahara
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: R21 MH080611
– fundername: NIMH NIH HHS
  grantid: R01 MH094160
– fundername: NIMH NIH HHS
  grantid: MH080611
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABGSF
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABTEW
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HMQ
HVGLF
HZ~
IHE
J1W
KOM
L7B
LX8
M29
M2V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SSH
SSN
SSU
SSZ
T5K
WUQ
X7M
Z5R
ZGI
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
DOVZS
EFLBG
LCYCR
ZA5
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
H94
7X8
5PM
ID FETCH-LOGICAL-c639t-849fc0af4ef0bfd4a4c1918ecb47e91ee2bd31d77a2b7527e6e7db1d653f03a73
IEDL.DBID AIKHN
ISSN 0022-510X
1878-5883
IngestDate Thu Aug 21 13:40:32 EDT 2025
Fri Jul 11 03:25:46 EDT 2025
Fri Jul 11 09:03:45 EDT 2025
Mon Jul 21 06:07:20 EDT 2025
Mon Jul 21 09:13:55 EDT 2025
Thu Apr 24 23:06:38 EDT 2025
Tue Jul 01 01:13:49 EDT 2025
Fri Feb 23 02:30:02 EST 2024
Sun Feb 23 10:18:46 EST 2025
Tue Aug 26 16:47:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HIV/AIDS
SSA
Cameroon
IHDS
Risk factors
Dementia
Immunopathology
Nervous system diseases
Cognitive disorder
AIDS
Immune deficiency
Hand
Infection
Viral disease
Risk factor
Degenerative disease
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c639t-849fc0af4ef0bfd4a4c1918ecb47e91ee2bd31d77a2b7527e6e7db1d653f03a73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 19631349
PQID 20829645
PQPubID 23462
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4906943
proquest_miscellaneous_734041568
proquest_miscellaneous_20829645
pubmed_primary_19631349
pascalfrancis_primary_22347994
crossref_citationtrail_10_1016_j_jns_2009_06_043
crossref_primary_10_1016_j_jns_2009_06_043
elsevier_sciencedirect_doi_10_1016_j_jns_2009_06_043
elsevier_clinicalkeyesjournals_1_s2_0_S0022510X09006868
elsevier_clinicalkey_doi_10_1016_j_jns_2009_06_043
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-10-15
PublicationDateYYYYMMDD 2009-10-15
PublicationDate_xml – month: 10
  year: 2009
  text: 2009-10-15
  day: 15
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle Journal of the neurological sciences
PublicationTitleAlternate J Neurol Sci
PublicationYear 2009
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Tozzi, Narciso, Galgani, Sette, Balestra, Gerace, Pau, Pigorini, Volpini, Camporiondo, Giulianelli, Visco (bib11) 1993; 7
Robertson, Kopnisky, Hakim, Merry, Nakasujja, Hall, Traore, Sacktor, Clifford, Newton, Van Rie, Holding, Clements, Zink, Mielke, Hosseinipour, Lalloo, Amod, Marra, Evans, Liner (bib14) 2008; 14
Ford, Mills, Calmy (bib30) 2009; 360
Ongolo-Zogo, Amana, Njamnshi, Magny-Tiam, Kamga, Gonsu (bib3) 2000; 2
Njamnshi, Djientcheu, Fonsah, Yepnjio, Njamnshi, Muna (bib2) 2008; 49
Heaton, Franklin, Clifford (bib29) 2009
Shanbhag, Rutstein, Zaoutis, Zhao, Chao, Radcliffe (bib10) 2005; 159
Evers, Rahmann, Schwaag, Frese, Reichelt, Husstedt (bib28) 2004; 20
Wong, Robertson, Nakasujja, Skolasky, Musisi, Katabira, McArthur, Ronald, Sacktor (bib18) 2007; 68
Valcour, Shikuma, Shiramizu, Watters, Poff, Selnes, Holck, Grove, Sacktor (bib34) 2004; 63
Sacktor, Wong, Nakasujja, Skolasky, Selnes, Musisi, Robertson, McArthur, Ronald, Katabira (bib19) 2005; 19
Brokering, Qaqish (bib21) 2003; 23
Chiesi, Vella, Dally, Pedersen, Danner, Johnson, Schwander, Goebel, Glauser, Antunes (bib16) 1996; 11
Ferrando, van Gorp, McElhiney, Goggin, Sewell, Rabkin (bib22) 1998; 12
Pitt, Myer, Wood (bib32) 2009; 12
Tozzi, Balestra, Lorenzini, Bellagamba, Galgani, Corpologo, Vlassi, Larussa, Zaccareli, Noto, Visco-Comandini, Giulianelli, Ippolito, Antinori, Narciso (bib15) 2005; 11
Antinori, Arendt, Becker, Brew, Byrd, Cherner, Clifford, Cinque, Epstein, Goodkin, Gisslen, Grant, Heaton, Joseph, Marder, Marra, McArthur, Nunn, Price, Pulliam, Robertson, Sacktor, Valcour, Wojna (bib35) 2007; 69
Childs, Lyles, Selnes, Chen, Miller, Cohen, Becker, Mellors, McArthur (bib24) 1999; 52
McArthur, Hoover, Bacellar, Miller, Cohen, Becker, Graham, McArthur, Selnes, Jacobson (bib17) 1993; 43
Brinkhof, Boulle, Weigel, Messou, Mathers, Orrell, Dabis, Pascoe, Egger (bib31) 2009; 6
Sacktor, Nakasujja, Skolasky (bib9) 2006; 67
Dongmo, Njamnshi, Kaptue, Tenaguem, Djientcheu V de, Ongolo-Zogo, Yepnjio (bib4) 2003; 12
Ferrando, Rabkin, Van Gorp, Lin, McElhiney (bib5) 2003; 15
Sacktor, Nakasujja, Skolasky, Robertson, Musisi, Ronald, Katabira, Clifford (bib27) 2009; 72
UNAIDS Report on the Global AIDS Epidemic, July 2008;2008.
Tozzi (bib26) 2004; 507
Bryden (bib20) 1977; 15
Chang, Ernst, Leonido-Yee, Witt, Speck, Walot, Miller (bib23) 1999; 53
Sacktor, Skolasky, Lyles, Esposito, Selnes, McArthur (bib8) 2000; 6
Tozzi, Balestra, Galgani, Narciso, Ferri, Sebastiani, D'Amato, Affricano, Pigorini, Pau, De Felici, Benedetto (bib12) 1999; 3
Sacktor, McDermott, Marder, Schifitto, Selnes, McArthur, Stern, Albert, Palumbo, Kieburtz, De Marcaida, Cohen, Epstein (bib25) 2002; 8
Robertson, Robertson, Ford, Watson, Fiscus, Harp, Hall (bib6) 2004; 36
Saavedra-Lozano, Ramos, Sanz, Navarro, De Jose, Martin-Fontelos, Mellado, Leal, Rodriguez, Luque, Madison, Irlbeck, Lanier, Ramilo (bib7) 2006; 1152
Kissel, Pukay-Martin, Bornstein (bib33) 2005; 17
Tozzi, Balestra, Galgani, Narciso, Sampaolesi, Antinori, Giulianelli, Serraino, Ippolito (bib13) 2001; 28
Dongmo (10.1016/j.jns.2009.06.043_bib4) 2003; 12
Ongolo-Zogo (10.1016/j.jns.2009.06.043_bib3) 2000; 2
Brokering (10.1016/j.jns.2009.06.043_bib21) 2003; 23
Tozzi (10.1016/j.jns.2009.06.043_bib11) 1993; 7
Kissel (10.1016/j.jns.2009.06.043_bib33) 2005; 17
Bryden (10.1016/j.jns.2009.06.043_bib20) 1977; 15
Sacktor (10.1016/j.jns.2009.06.043_bib27) 2009; 72
Shanbhag (10.1016/j.jns.2009.06.043_bib10) 2005; 159
Heaton (10.1016/j.jns.2009.06.043_bib29) 2009
Tozzi (10.1016/j.jns.2009.06.043_bib12) 1999; 3
Sacktor (10.1016/j.jns.2009.06.043_bib9) 2006; 67
Valcour (10.1016/j.jns.2009.06.043_bib34) 2004; 63
Childs (10.1016/j.jns.2009.06.043_bib24) 1999; 52
Tozzi (10.1016/j.jns.2009.06.043_bib13) 2001; 28
Njamnshi (10.1016/j.jns.2009.06.043_bib2) 2008; 49
Saavedra-Lozano (10.1016/j.jns.2009.06.043_bib7) 2006; 1152
Ford (10.1016/j.jns.2009.06.043_bib30) 2009; 360
Sacktor (10.1016/j.jns.2009.06.043_bib19) 2005; 19
Chiesi (10.1016/j.jns.2009.06.043_bib16) 1996; 11
Antinori (10.1016/j.jns.2009.06.043_bib35) 2007; 69
Ferrando (10.1016/j.jns.2009.06.043_bib22) 1998; 12
Evers (10.1016/j.jns.2009.06.043_bib28) 2004; 20
McArthur (10.1016/j.jns.2009.06.043_bib17) 1993; 43
Chang (10.1016/j.jns.2009.06.043_bib23) 1999; 53
Ferrando (10.1016/j.jns.2009.06.043_bib5) 2003; 15
Wong (10.1016/j.jns.2009.06.043_bib18) 2007; 68
Sacktor (10.1016/j.jns.2009.06.043_bib8) 2000; 6
Pitt (10.1016/j.jns.2009.06.043_bib32) 2009; 12
Robertson (10.1016/j.jns.2009.06.043_bib14) 2008; 14
Sacktor (10.1016/j.jns.2009.06.043_bib25) 2002; 8
Brinkhof (10.1016/j.jns.2009.06.043_bib31) 2009; 6
10.1016/j.jns.2009.06.043_bib1
Robertson (10.1016/j.jns.2009.06.043_bib6) 2004; 36
Tozzi (10.1016/j.jns.2009.06.043_bib15) 2005; 11
Tozzi (10.1016/j.jns.2009.06.043_bib26) 2004; 507
References_xml – volume: 12
  start-page: F65
  year: 1998
  end-page: F70
  ident: bib22
  article-title: Highly active anti-retroviral treatment in HIV infection: benefits for neuropsychological function
  publication-title: AIDS
– volume: 20
  start-page: 483
  year: 2004
  end-page: 491
  ident: bib28
  article-title: Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance
  publication-title: AIDS Research and Human Retroviruses
– volume: 36
  start-page: 562
  year: 2004
  end-page: 566
  ident: bib6
  article-title: Highly active antiretroviral therapy improves neurocognitive functioning
  publication-title: J Acquir Immune Defic Syndr
– volume: 28
  start-page: 19
  year: 2001
  end-page: 27
  ident: bib13
  article-title: Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years
  publication-title: J Acquir Immune Defic Syndr
– volume: 8
  start-page: 136
  year: 2002
  end-page: 142
  ident: bib25
  article-title: HIV-associated cognitive impairment before and after the advent of combination therapy
  publication-title: J NeuroVirol
– volume: 6
  start-page: 84
  year: 2000
  end-page: 88
  ident: bib8
  article-title: Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors
  publication-title: J NeuroVirol
– volume: 53
  start-page: 782
  year: 1999
  end-page: 789
  ident: bib23
  article-title: Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
  publication-title: Neurology
– volume: 1152
  year: 2006
  ident: bib7
  article-title: Salvage therapy with abacavir and other reverse transcriptase inhibitors for human imunodeficiency-associated encephalopathy
  publication-title: Pediatr Infect Dis J 25, 1142–
– start-page: 2009
  year: 2009
  ident: bib29
  article-title: HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: the CHARTER study
  publication-title: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections
– reference: UNAIDS Report on the Global AIDS Epidemic, July 2008;2008.
– volume: 15
  year: 1977
  ident: bib20
  article-title: Measuring handedness with questionnaires
  publication-title: Neuropsychologia
– volume: 360
  start-page: 1808
  year: 2009
  end-page: 1810
  ident: bib30
  article-title: Rationing antiretroviral therapy in Africa—treating too few, too late
  publication-title: N Engl J Med
– volume: 11
  start-page: 39
  year: 1996
  end-page: 44
  ident: bib16
  article-title: Epidemiology of AIDS Dementia Complex in Europe. AIDS in Europe Study Group
  publication-title: J Acquir immune Defic Syndr Hum Retrovirol
– volume: 7
  start-page: 683
  year: 1993
  end-page: 692
  ident: bib11
  article-title: Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex
  publication-title: AIDS
– volume: 11
  start-page: 265
  year: 2005
  end-page: 273
  ident: bib15
  article-title: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996–2002: results from an urban observational cohort
  publication-title: J Neurovirol
– volume: 17
  start-page: 180
  year: 2005
  end-page: 184
  ident: bib33
  article-title: The relationship between age and cognitive function in HIV-infected men
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 15
  start-page: 208
  year: 2003
  end-page: 214
  ident: bib5
  article-title: Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 23
  start-page: 1475
  year: 2003
  end-page: 1485
  ident: bib21
  article-title: Management of anemia of chronic disease in patients with the human immunodeficiency virus
  publication-title: Pharmacotherapy
– volume: 69
  start-page: 1789
  year: 2007
  end-page: 1799
  ident: bib35
  article-title: Updated research nosology for HIV-associated neurocognitive disorders
  publication-title: Neurology
– volume: 159
  start-page: 651
  year: 2005
  end-page: 656
  ident: bib10
  article-title: Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy
  publication-title: Arch Pediatr Adolesc Med
– volume: 507
  year: 2004
  ident: bib26
  article-title: Neurocognitive impairment and survival in HIV-positive patients treated with HAART: results from an urban observational cohort
  publication-title: Eleventh Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract
– volume: 6
  start-page: 1
  year: 2009
  end-page: 10.e1000066
  ident: bib31
  article-title: International Epidemiological Databases to Evaluate AIDS (IeDEA). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality
  publication-title: PLoS Med
– volume: 68
  start-page: 350
  year: 2007
  end-page: 355
  ident: bib18
  article-title: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
  publication-title: Neurology
– volume: 12
  start-page: 5
  year: 2009
  ident: bib32
  article-title: Quality of life and the impact of drug toxicities in a South African community antiretroviral programme
  publication-title: Journal of the International AIDS Society
– volume: 63
  start-page: 822
  year: 2004
  end-page: 827
  ident: bib34
  article-title: Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort
  publication-title: Neurology
– volume: 2
  start-page: 17
  year: 2000
  end-page: 22
  ident: bib3
  article-title: Aspects cliniques et scanographiques des lésions cérébrales chez l'adulte camerounais VIH positif: à propos de 94 cas
  publication-title: Health Sci Dis.
– volume: 12
  start-page: 11
  year: 2003
  end-page: 12
  ident: bib4
  article-title: Aspects cliniques et étiologiques des encéphalopathies chez le sujet VIH positif à Yaoundé
  publication-title: Journal Camerounais de Médecine.
– volume: 52
  start-page: 607
  year: 1999
  end-page: 613
  ident: bib24
  article-title: Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
  publication-title: Neurology
– volume: 43
  start-page: 2245
  year: 1993
  end-page: 2252
  ident: bib17
  article-title: Dementia in AIDS patients: incidence and risk factors
  publication-title: Neurology
– volume: 72
  start-page: 165
  year: 2009
  end-page: 170
  ident: bib27
  article-title: Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
  publication-title: Neurology
– volume: 49
  start-page: 393
  year: 2008
  end-page: 397
  ident: bib2
  article-title: The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon
  publication-title: Journal of Acquired Immune Deficiency Syndromes
– volume: 19
  start-page: 1367
  year: 2005
  end-page: 1374
  ident: bib19
  article-title: The International HIV Dementia scale: a new rapid screening test for HIV dementia
  publication-title: AIDS
– volume: 14
  start-page: 89
  year: 2008
  end-page: 101
  ident: bib14
  article-title: On behalf of the second Assessment of NeuroAIDS in Africa Conference Participants
  publication-title: J Neurovirol
– volume: 67
  start-page: 311
  year: 2006
  end-page: 314
  ident: bib9
  article-title: Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa
  publication-title: Neurology
– volume: 3
  start-page: 1889
  year: 1999
  end-page: 1897
  ident: bib12
  article-title: Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment
  publication-title: AIDS
– volume: 7
  start-page: 683
  issue: 5
  year: 1993
  ident: 10.1016/j.jns.2009.06.043_bib11
  article-title: Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex
  publication-title: AIDS
  doi: 10.1097/00002030-199305000-00012
– volume: 12
  start-page: F65
  issue: 8
  year: 1998
  ident: 10.1016/j.jns.2009.06.043_bib22
  article-title: Highly active anti-retroviral treatment in HIV infection: benefits for neuropsychological function
  publication-title: AIDS
  doi: 10.1097/00002030-199808000-00002
– volume: 53
  start-page: 782
  issue: 4
  year: 1999
  ident: 10.1016/j.jns.2009.06.043_bib23
  article-title: Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
  publication-title: Neurology
  doi: 10.1212/WNL.53.4.782
– volume: 14
  start-page: 89
  issue: 2
  year: 2008
  ident: 10.1016/j.jns.2009.06.043_bib14
  article-title: On behalf of the second Assessment of NeuroAIDS in Africa Conference Participants
  publication-title: J Neurovirol
  doi: 10.1080/13550280701829793
– volume: 49
  start-page: 393
  issue: 4
  year: 2008
  ident: 10.1016/j.jns.2009.06.043_bib2
  article-title: The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon
  publication-title: Journal of Acquired Immune Deficiency Syndromes
  doi: 10.1097/QAI.0b013e318183a9df
– volume: 6
  start-page: 1
  issue: 4
  year: 2009
  ident: 10.1016/j.jns.2009.06.043_bib31
  article-title: International Epidemiological Databases to Evaluate AIDS (IeDEA). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000066
– volume: 11
  start-page: 265
  year: 2005
  ident: 10.1016/j.jns.2009.06.043_bib15
  article-title: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996–2002: results from an urban observational cohort
  publication-title: J Neurovirol
  doi: 10.1080/13550280590952790
– volume: 3
  start-page: 1889
  issue: 14
  year: 1999
  ident: 10.1016/j.jns.2009.06.043_bib12
  article-title: Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment
  publication-title: AIDS
  doi: 10.1097/00002030-199910010-00011
– volume: 15
  start-page: 208
  year: 2003
  ident: 10.1016/j.jns.2009.06.043_bib5
  article-title: Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection
  publication-title: J Neuropsychiatry Clin Neurosci
  doi: 10.1176/jnp.15.2.208
– ident: 10.1016/j.jns.2009.06.043_bib1
– volume: 6
  start-page: 84
  year: 2000
  ident: 10.1016/j.jns.2009.06.043_bib8
  article-title: Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors
  publication-title: J NeuroVirol
  doi: 10.3109/13550280009006385
– volume: 2
  start-page: 17
  year: 2000
  ident: 10.1016/j.jns.2009.06.043_bib3
  article-title: Aspects cliniques et scanographiques des lésions cérébrales chez l'adulte camerounais VIH positif: à propos de 94 cas
  publication-title: Health Sci Dis.
– volume: 28
  start-page: 19
  year: 2001
  ident: 10.1016/j.jns.2009.06.043_bib13
  article-title: Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/00042560-200109010-00004
– volume: 12
  start-page: 11
  issue: 1
  year: 2003
  ident: 10.1016/j.jns.2009.06.043_bib4
  article-title: Aspects cliniques et étiologiques des encéphalopathies chez le sujet VIH positif à Yaoundé
  publication-title: Journal Camerounais de Médecine.
– volume: 159
  start-page: 651
  year: 2005
  ident: 10.1016/j.jns.2009.06.043_bib10
  article-title: Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy
  publication-title: Arch Pediatr Adolesc Med
  doi: 10.1001/archpedi.159.7.651
– volume: 67
  start-page: 311
  issue: 2
  year: 2006
  ident: 10.1016/j.jns.2009.06.043_bib9
  article-title: Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000225183.74521.72
– volume: 52
  start-page: 607
  issue: 3
  year: 1999
  ident: 10.1016/j.jns.2009.06.043_bib24
  article-title: Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
  publication-title: Neurology
  doi: 10.1212/WNL.52.3.607
– volume: 11
  start-page: 39
  issue: 1
  year: 1996
  ident: 10.1016/j.jns.2009.06.043_bib16
  article-title: Epidemiology of AIDS Dementia Complex in Europe. AIDS in Europe Study Group
  publication-title: J Acquir immune Defic Syndr Hum Retrovirol
  doi: 10.1097/00042560-199601010-00005
– volume: 8
  start-page: 136
  issue: 2
  year: 2002
  ident: 10.1016/j.jns.2009.06.043_bib25
  article-title: HIV-associated cognitive impairment before and after the advent of combination therapy
  publication-title: J NeuroVirol
  doi: 10.1080/13550280290049615
– volume: 68
  start-page: 350
  issue: 5
  year: 2007
  ident: 10.1016/j.jns.2009.06.043_bib18
  article-title: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000252811.48891.6d
– volume: 20
  start-page: 483
  issue: 5
  year: 2004
  ident: 10.1016/j.jns.2009.06.043_bib28
  article-title: Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance
  publication-title: AIDS Research and Human Retroviruses
  doi: 10.1089/088922204323087723
– volume: 12
  start-page: 5
  year: 2009
  ident: 10.1016/j.jns.2009.06.043_bib32
  article-title: Quality of life and the impact of drug toxicities in a South African community antiretroviral programme
  publication-title: Journal of the International AIDS Society
  doi: 10.1186/1758-2652-12-5
– volume: 15
  issue: 4–5
  year: 1977
  ident: 10.1016/j.jns.2009.06.043_bib20
  article-title: Measuring handedness with questionnaires
  publication-title: Neuropsychologia
– volume: 43
  start-page: 2245
  issue: 11
  year: 1993
  ident: 10.1016/j.jns.2009.06.043_bib17
  article-title: Dementia in AIDS patients: incidence and risk factors
  publication-title: Neurology
  doi: 10.1212/WNL.43.11.2245
– volume: 72
  start-page: 165
  year: 2009
  ident: 10.1016/j.jns.2009.06.043_bib27
  article-title: Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000339042.96109.86
– start-page: 2009
  year: 2009
  ident: 10.1016/j.jns.2009.06.043_bib29
  article-title: HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: the CHARTER study
– volume: 36
  start-page: 562
  year: 2004
  ident: 10.1016/j.jns.2009.06.043_bib6
  article-title: Highly active antiretroviral therapy improves neurocognitive functioning
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/00126334-200405010-00003
– volume: 360
  start-page: 1808
  issue: 18
  year: 2009
  ident: 10.1016/j.jns.2009.06.043_bib30
  article-title: Rationing antiretroviral therapy in Africa—treating too few, too late
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp0902820
– volume: 69
  start-page: 1789
  year: 2007
  ident: 10.1016/j.jns.2009.06.043_bib35
  article-title: Updated research nosology for HIV-associated neurocognitive disorders
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000287431.88658.8b
– volume: 507
  year: 2004
  ident: 10.1016/j.jns.2009.06.043_bib26
  article-title: Neurocognitive impairment and survival in HIV-positive patients treated with HAART: results from an urban observational cohort
  publication-title: Eleventh Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract
– volume: 19
  start-page: 1367
  year: 2005
  ident: 10.1016/j.jns.2009.06.043_bib19
  article-title: The International HIV Dementia scale: a new rapid screening test for HIV dementia
  publication-title: AIDS
– volume: 1152
  year: 2006
  ident: 10.1016/j.jns.2009.06.043_bib7
  article-title: Salvage therapy with abacavir and other reverse transcriptase inhibitors for human imunodeficiency-associated encephalopathy
  publication-title: Pediatr Infect Dis J 25, 1142–
– volume: 23
  start-page: 1475
  issue: 11
  year: 2003
  ident: 10.1016/j.jns.2009.06.043_bib21
  article-title: Management of anemia of chronic disease in patients with the human immunodeficiency virus
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.23.14.1475.31949
– volume: 17
  start-page: 180
  year: 2005
  ident: 10.1016/j.jns.2009.06.043_bib33
  article-title: The relationship between age and cognitive function in HIV-infected men
  publication-title: J Neuropsychiatry Clin Neurosci
  doi: 10.1176/jnp.17.2.180
– volume: 63
  start-page: 822
  issue: 3
  year: 2004
  ident: 10.1016/j.jns.2009.06.043_bib34
  article-title: Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000134665.58343.8D
SSID ssj0006889
Score 2.1397622
Snippet The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The...
AbstractBackgroundThe prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 149
SubjectTerms Acquired immune deficiency syndrome
Adolescent
Adult
Africa South of the Sahara - epidemiology
AIDS Dementia Complex - blood
AIDS Dementia Complex - epidemiology
AIDS Dementia Complex - immunology
Biological and medical sciences
Cameroon
Cameroon - epidemiology
CD4 Lymphocyte Count
Cognition Disorders - blood
Cognition Disorders - epidemiology
Cognition Disorders - immunology
Cross-Sectional Studies
Dementia
Female
Hemoglobins - metabolism
HIV Infections - blood
HIV Infections - epidemiology
HIV Infections - immunology
HIV/AIDS
Human immunodeficiency virus
Human viral diseases
Humans
IHDS
Infectious diseases
Male
Medical sciences
Middle Aged
Neurology
Prevalence
Risk Factors
Severity of Illness Index
SSA
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Young Adult
Title Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0022510X09006868
https://www.clinicalkey.es/playcontent/1-s2.0-S0022510X09006868
https://dx.doi.org/10.1016/j.jns.2009.06.043
https://www.ncbi.nlm.nih.gov/pubmed/19631349
https://www.proquest.com/docview/20829645
https://www.proquest.com/docview/734041568
https://pubmed.ncbi.nlm.nih.gov/PMC4906943
Volume 285
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELb6kBASQrwJj8UHDoCU1omd2Oa2Wqi2oO4BKFpOlmM7Im3Jrsjulf_D7-CP4UmcwEJbJK6JJ4ntz-NxZuYbhJ5mWguTCagR5o8ojJgkFiWTsRV5aYQTecEh3_lolk-P2Zt5Nt9Ckz4XBsIqg-7vdHqrrcOV_TCa-8uqghxfj8WEzIls8xzENtpNqcw9tHfHh2-ns0Eh50LInjQcBHrnZhvmdVI3gbUy3yOMXrQ9XVvqxg9a2VW7OM8c_TOq8rdt6uAGuh7sSzzuunATbbn6FrpyFDzot9HqXdWc4lBlB3uLFU8PP8Y6TJKzuCW4HIKKsA3snA1-Nh3PXj3HVY2bdRG_18D0XOOuztBL7OGGjd8R8aLEnzTUavrxPZ7oL85b5vUddHzw-sNkGofKC7HxFssqFkyWhuiSuZIUpWWaGX-uE84UjDuZOJcWliaWc50WPEu5yx23RWLzjJaEak7vop16Ubv7CEuSaWuohV-NzMLca25Z7oWpJUWWRoj0A65MoCWH6hhnqo8_O1F-jqBcplQQg8dohF4MIsuOk-Oyxmk_i6pPNvXqUfkd4zIhfp6Qa8ICb1SimlQR9RcII8QGyQ0c_-uFow2ADf3y1hvjUrIIPekRp7wCAK-Ort1iDU8R4DrPIoQvaMEpAyIG-Lh7HUR_DZvXv0BQ6Tu8Ad6hAbCPb96pq88tCzmTkDNNH_xfhx-iq61fDmKDskdoZ_V17R57825VjND23rdkFBbxT_-OUMk
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKkQAJIf4JP60PHAAprRM7sc2tWqi20N0DtGg5WY7tiBTIrsjulffhOXgxPImTstAWiWviSTL2zHicmfkGoaeZ1sJkAnqE-SMKIyaJRclkbEVeGuFEXnCod55M8_ExezPLZhto1NfCQFplsP2dTW-tdbiyG2Zzd1FVUOPrZTEhMyLbOgdxCV1mXn1BO3e-n-Z55ELIHjIchvehzTbJ66RuAmZlvkMYPW9zur7QjZ-ysut1cZYz-mdO5W-b1P5NdCN4l3ivY-AW2nD1bXRlEuLnd9DyXdV8xqHHDvb-Kh4ffIh1WCJncQtvOaQUYRuwORv8bLw3ffUcVzVuVkX8XgPOc427LkMvsRc2bPx-iOcl_qihU9PPH_FIf3XeL6_vouP910ejcRz6LsTG-yvLWDBZGqJL5kpSlJZpZvypTjhTMO5k4lxaWJpYznVa8CzlLnfcFonNM1oSqjm9hzbree0eICxJpq2hFn40Mgsrr7lluSemlhRZGiHST7gyAZQcemN8UX322YnyawTNMqWCDDxGI_RiIFl0iBwXDU77VVR9qak3jsrvFxcR8bOIXBPUu1GJalJF1F8iGCE2UK5J8b9euLUmYANf3ndjXEoWoe1e4pRXf4jp6NrNV_AUAYHzLEL4nBGcMoBhgI-734no6bR56wvwlJ7hNeEdBgD2-PqduvrUYpAzCRXT9OH_MbyNro6PJofq8GD69hG61kboIEsoe4w2l99W7ol39JbFVqvIvwDNPlGN
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+factors+for+HIV%E2%80%95associated+neurocognitive+disorders+%28HAND%29+in+sub%E2%80%95Saharan+Africa%3A+The+case+of+Yaound%C3%A9%E2%80%95Cameroon&rft.jtitle=Journal+of+the+neurological+sciences&rft.au=NJAMNSHI%2C+A.+K&rft.au=ZOUNG-KANYI+BISSEK%2C+A.+C&rft.au=NJAMNSHI%2C+D.+M&rft.au=KOUANFACK%2C+C&rft.date=2009-10-15&rft.pub=Elsevier&rft.issn=0022-510X&rft.volume=285&rft.issue=1-2&rft.spage=149&rft.epage=153&rft_id=info:doi/10.1016%2Fj.jns.2009.06.043&rft.externalDBID=n%2Fa&rft.externalDocID=22347994
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0022510X%2FS0022510X09X00109%2Fcov150h.gif